Gustave Roussy immune score predicts survival outcome of patients with metastatic urothelial carcinoma treated with pembrolizumab: A multicenter study of 321 patients (YUSHIMA study)

被引：0
|
作者：
Tanabe, K. [1 ]
Shuichiro, K. [1 ]
Katsushi, N. [2 ]
Junji, Y. [3 ]
Yukihiro, O. [4 ]
Tetsuo, O. [5 ]
Ryoji, T. [6 ]
Akira, N. [1 ]
Masataka, Y. [7 ]
Tetsuro, T. [8 ]
Kazutaka, S. [9 ]
Yasuyuki, S. [10 ]
Fumitaka, K. [11 ]
Yukio, K. [12 ]
Hajime, T. [13 ]
Soichiro, Y. [13 ]
Yasuhisa, F. [13 ]
机构：
[1] Saitama Red Cross Hosp, Dept Urol, Saitama, Japan
[2] Kohnodai Hosp, Dept Urol, Chiba, Japan
[3] Canc Inst Hosp, Dept Urol, Tokyo, Japan
[4] Japanese Red Cross Omori Hosp, Dept Urol, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Urol, Ibaraki, Japan
[6] Tokyo Metropolitan Otsuka Hosp, Dept Urol, Tokyo, Japan
[7] Tokyo Metropolitan Tama Nambu Chiiki Hosp, Dept Urol, Tokyo, Japan
[8] Showa Gen Hosp, Dept Urol, Tokyo, Japan
[9] Dokkyo Med Univ Saitama Med Ctr, Dept Urol, Saitama, Japan
[10] Tsuchiura Kyodo Gen Hosp, Dept Urol, Ibaraki, Japan
[11] Komagome Hosp, Dept Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[12] Saitama Prefectural Canc Ctr, Dept Urol, Saitama, Japan
[13] Tokyo Med & Dent Univ, Dept Urol, Tokyo, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0752
引用
收藏
页码：S1729 / S1730
页数：2
相关论文
共 50 条
  • [31] Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma
    Ishiyama, Yudai
    Kondo, Tsunenori
    Nemoto, Yuki
    Kobari, Yuki
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Hashimoto, Yasunobu
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 834.e21 - 834.e28
  • [32] Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
    Furubayashi, Nobuki
    Minato, Akinori
    Negishi, Takahito
    Sakamoto, Naotaka
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Masaoka, Hiroyuki
    Harada, Mirii
    Tamura, Shingo
    Kobayashi, Hiroki
    Morihara, Kaede
    Kuroiwa, Kentaro
    Seki, Narihito
    Fujimoto, Naohiro
    Nakamura, Motonobu
    ANTICANCER RESEARCH, 2023, 43 (10) : 4701 - 4708
  • [33] The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma
    Chen, Cui
    Sun, Peng
    Dai, Qiang-sheng
    Weng, Hui-wen
    Li, He-ping
    Ye, Sheng
    PLOS ONE, 2014, 9 (11):
  • [34] Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Ubukata, Yasunari
    Kuriyama, Kengo
    Kimura, Akiharu
    Kogure, Norimichi
    Hosaka, Hisashi
    Naganuma, Atsushi
    Sekiguchi, Masanori
    Saito, Kana
    Ogata, Kyoichi
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7400 - 7406
  • [35] Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study
    Kang, Ho Won
    Seo, Sung Pil
    Kim, Won Tae
    Kim, Yong-June
    Yun, Seok Joong
    Lee, Sang-Cheol
    Choi, Young Deuk
    Ha, Yun-Sok
    Kim, Tae-Hwan
    Kwon, Tae Gyun
    Byun, Seok-Soo
    Jeh, Seong Uk
    Kim, Wun-Jae
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (02) : 335 - 342
  • [36] Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
    Brown, Jacqueline T.
    Liu, Yuan
    Shabto, Julie M.
    Martini, Dylan J.
    Ravindranathan, Deepak
    Hitron, Emilie Elise
    Russler, Greta Anne
    Caulfield, Sarah
    Yantorni, Lauren Beth
    Joshi, Shreyas S.
    Kissick, Haydn
    Ogan, Kenneth
    Harris, Wayne B.
    Carthon, Bradley C.
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    ONCOLOGIST, 2021, 26 (05): : 397 - 405
  • [37] Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
    Kobayashi, Mizuki
    Narita, Shintaro
    Matsui, Yoshiyuki
    Kanda, Souhei
    Hidaka, Yu
    Abe, Hiroyasu
    Tsuzuki, Toyonori
    Ito, Katsuhiro
    Kojima, Takahiro
    Kato, Minoru
    Hatakeyama, Shingo
    Matsushita, Yuto
    Naito, Sei
    Shiga, Masanobu
    Miyake, Makito
    Muro, Yusuke
    Nakanishi, Shotaro
    Kato, Yoichiro
    Shibuya, Tadamasa
    Hayashi, Tetsutaro
    Yasumoto, Hiroaki
    Yoshida, Takashi
    Uemura, Motohide
    Taoka, Rikiya
    Kamiyama, Manabu
    Morita, Satoshi
    Habuchi, Tomonori
    Ogawa, Osamu
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kobayashi, Takashi
    BJU INTERNATIONAL, 2022, 130 (02) : 226 - 234
  • [38] MELD SCORE PREDICTS OUTCOME OF PATIENTS WITH ADVANCEED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Gardini, A. Casadei
    Faloppi, L.
    Marisi, G.
    Foschi, F. G.
    Donati, G.
    Scartozzi, M.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E52 - E52
  • [39] Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study
    Shindo, Tetsuya
    Hashimoto, Kohei
    Kenuka, Toshiki
    Miyamoto, Shintaro
    Hiyama, Yoshiki
    Fukuta, Fumimasa
    Kunishima, Yasuharu
    Okada, Manabu
    Matsukawa, Masanori
    Kato, Ryuichi
    Senda, Masaya
    Wanifuchi, Atsushi
    Sato, Shunsuke
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    JOURNAL OF GERIATRIC ONCOLOGY, 2025, 16 (02)
  • [40] Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study
    Minato, Akinori
    Furubayashi, Nobuki
    Nagata, Yujiro
    Tomoda, Toshihisa
    Masaoka, Hiroyuki
    Song, Yoohyun
    Hori, Yoshifumi
    Kiyoshima, Keijiro
    Negishi, Takahito
    Kuroiwa, Kentaro
    Seki, Narihito
    Tomisaki, Ikko
    Harada, Kenichi
    Nakamura, Motonobu
    Fujimoto, Naohiro
    CURRENT ONCOLOGY, 2024, 31 (02) : 862 - 871
12345